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Toxicity of nanoparticles (NPs) of Fe3O4 produced by a chemical technique and 
nanoparticles of Ag, Au, CuO, NiO, Mn3O4, PbO, ZnO, TiO2, SiO2, Al2O3 generated through laser 
ablation was unvestigated with the help of a single intra-tracheal and repeated intra-peritoneal 
injections in non-lethal doses. Besides, we carried out long-term inhalation experiments with low 
concentrations of Fe2O3-NP, SiO2-NP or NiO-NP and in vitro experiments on established cell lines 
with NPs of NiO, Mn3O4, PbO, CuO and CdO.  
It was proved that these NPs are much more toxic compared to their fine micrometric or 
even submicron counterparts and are usually the more toxic the smaller their dimensions within 
the nano-scale range. We found also that toxicity of Me-NPs strongly depends on their chemical 
nature, solubility and mechanisms of action specific for a particular metal. Solubilization of Me-
NPs in biological milieus plays an important role in their toxicokinetic which can prevail over that 
of the physiological mechanisms controlling their distribution, retention and elimination. On the 
other hand, thanks to the high activity of these mechanisms, the organism is not defenseless against 
the impact of Me-NPs. 
The nonspecific responses of the organism to the impact of Me-NP included: changes in the 
cytological and some biochemical characteristics of the bronchoalveolar lavage fluid caused by 
the deposition of particles in the lower airways; various manifestations of systemic toxicity 
including always significant damage to the liver and kidneys; some cytological signs of a likely 
onset of hyperergic inflammation; moderate neurological disturbances associated with possible 
penetration of Me-NP into the brain from the blood as well as from the nasal mucous membrane 
along the olfactory pathway; a paradoxically low manifestation of pulmonary pathology due to 
low chronic retention of nanoparticles in the lungs; a genotoxic effect on the organism level. 
As a protective measure, the toxicity and even genotoxicity of Me-NPs can be significantly 
attenuated by adequately composed combinations of some bioactive agents in innocuous doses. 
  
